

Dr. Kathleen Walsh is a hospitalist who cares for hospitalized patients only and does not have out-patient practices.
Dr. Walsh is board certified in internal medicine. She is a General Medicine/Global Health Research Fellow at Weill Cornell. Her academic interests include research of the diagnosis and treatment of tuberculosis in resource-limited settings such as Haiti. She is also interested in medical resident education.
SARS-CoV-2 IgG seropositivity among people living with and without HIV in the first year of the COVID-19 pandemic in Haiti and Tanzania.
A human YEATS4 variant confers resistance to TST and IGRA conversion despite Mycobacterium tuberculosis exposure.
A Bedaquiline, Pyrazinamide, Levofloxacin, Linezolid, and Clofazimine Second-line Regimen for Tuberculosis Displays Similar Early Bactericidal Activity as the Standard Rifampin-Based First-line Regimen.